Repligen Corp (RGEN)
147.34
+0.39
(+0.27%)
USD |
NASDAQ |
Dec 26, 10:59
Repligen Cash from Investing (Quarterly): -5.859M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| West Pharmaceutical Services Inc | -82.10M |
| QuidelOrtho Corp | -56.50M |
| Perspective Therapeutics Inc | -29.74M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 49.32M |
| Cash from Financing (Quarterly) | -69.60M |
| Free Cash Flow | 131.26M |
| Free Cash Flow Per Share (Quarterly) | 0.7531 |
| Free Cash Flow to Equity (Quarterly) | 107.78M |
| Free Cash Flow to Firm (Quarterly) | 45.34M |
| Free Cash Flow Yield | 1.59% |